BPC 157: Experimental Peptide Creates Risk for Athletes The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York BPC 157 aka Wolverine. This peptide is not FDA approved, but it is very popular among the biohacking population. Ashley explains the science behind it, but remember, it doesn't have human data yet, so fda warning bpc 157 peptide products New Details 157 Peptides After Peptide Sciences Renew Vitality RFK Jr.'s peptide push could unleash risky drugs STAT First Opinion